Full Breakdown
Investigation Launched into Infant Death Linked to Recalled Nutrilon Formula
2/13/2026, 1:16:10 AM
Core Event: Infant Death and Formula Recall
The Israeli Health Ministry is conducting an investigation into the death of a four-week-old infant who died after consuming Nutrilon baby formula that had been recalled. The infant succumbed to respiratory failure at Samson Assuta Ashdod Hospital on February 3, 2023. Preliminary investigations indicated that the baby had ingested formula from batches that were subject to a nationwide recall due to concerns about elevated levels of cereulide, a toxin produced by the bacterium Bacillus cereus.
Background & Context: The Nutrilon Recall
The recall of Nutrilon formula began on January 30, 2023, when the Health Ministry, in collaboration with Teva Israel Ltd., announced the withdrawal of three specific batches after receiving reports from the European manufacturer regarding potential contamination. The recall was expanded on February 6 to include all Nutrilon AR and Stage 1 formula as a precautionary measure, despite no direct link between the recalled formula and the infant's death being established at that time.
Investigation Details
An autopsy conducted by the Abu Kabir National Institute of Forensic Medicine found no clinical link between the formula and the infant's death, but the Health Ministry has mandated further testing. The investigation will also examine the delay in reporting the infant's death to government officials. An external committee of medical experts has been appointed to ensure a thorough review of both clinical factors and communication breakdowns.
Health Risks Associated with Cereulide
Cereulide can cause gastrointestinal symptoms such as nausea and vomiting, particularly in infants, who are more susceptible to severe health complications. The European food safety body issued new guidance regarding cereulide levels on February 2, prompting additional recalls, including the expanded action in Israel. The Health Ministry emphasized that most of the affected batches had not reached retail markets, and only a limited number of units were sold to the public.
Criticism & Opposition: Historical Context
The incident has drawn attention to past failures in infant formula safety in Israel, notably the 2003 Remedia formula scandal, which resulted in the deaths of three infants and severe disabilities in others due to a lack of Vitamin B1. This history has raised concerns among parents and health advocates regarding the safety of infant nutrition products.
Official Statements & Responses
The Health Ministry has committed to "full transparency as the investigation proceeds toward its final conclusions." A spokesperson from the Ashdod hospital stated that a senior medical team had performed extensive resuscitation efforts for the infant, adhering to professional standards.
Conflicting Reports & Gaps
While the autopsy found no direct link between the formula and the infant's death, the ongoing investigation and additional testing may yield further insights. Additionally, French authorities are investigating the deaths of three infants linked to similar recalls, although no causal links have been established.
Verbatim Quotes
- “full transparency as the investigation proceeds toward its final conclusions.” — Health Ministry Statement
- “fought for his life, following all accepted professional standards and performing prolonged resuscitation efforts,” — Ashdod Hospital Spokesperson
This investigation highlights critical concerns regarding infant formula safety and the importance of timely communication in health crises.
